NCT00357383View on ClinicalTrials.gov

Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Eye Infections, Bacterial
Interventions
DRUG

Azithromycin (T1225)

Sponsors

Lead Sponsor

Laboratoires Thea
All Listed Sponsors
lead

Laboratoires Thea

INDUSTRY